help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 28, 2006
Molecular Endocrinology, doi:10.1210/me.2006-0096
A more recent version of this article appeared on January 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
21/1/293    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vidal, O. M.
Right arrow Articles by Flores-Morales, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vidal, O. M.
Right arrow Articles by Flores-Morales, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH

Submitted on February 27, 2006
Accepted on September 19, 2006

In vivo transcript profiling and phylogenetic analysis identifies SOCS2 as a direct STAT5b target in liver

Oscar M. Vidal, Roxana Merino, Elizabeth Rico-Bautista, Leandro Fernandez-Perez, Dennis J. Chia, Joachim Woelfle, Mitsuru Ono, Boris Lenhard, Gunnar Norstedt, Peter Rotwein, and Amilcar Flores-Morales*

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Molecular Endocrinology Group, Department of Clinical Sciences, University of Las Palmas de Gran Canaria - Spain.; Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon 97239-3098, USA.; Computational Biology Unit, Bergen Centre for Computational Science, University of Bergen, Norway

* To whom correspondence should be addressed. E-mail: Amilcar.Flores{at}ki.se.

The growth hormone (GH)-activated signal transducer and activator of transcription 5b (STAT5b) is an essential regulator of somatic growth. The transcriptional response to STAT5b in liver is poorly understood. We have combined microarray-based expression profiling and phylogenetic analysis of gene regulatory regions to study the interplay between STAT5b and GH in the regulation of hepatic gene expression. The acute transcriptional response to GH in vivo after a single pulse of GH was studied in the liver of hypophysectomized rats in the presence of either constitutively active (CA) or a dominant-negative (DN) STAT5b delivered by adenoviral gene transfer. Genes showing differential expression in these two situations were analyzed for the presence of STAT5b binding sites in promoter and intronic regions that are phylogenetically conserved between rats and humans. Using this approach, we showed that most rapid transcriptional effects of GH in the liver are not results of direct actions of STAT5b. In addition, we identified novel STAT5b cis regulatory elements in genes such as Frizzled-4, epithelial membrane protein-1 and the suppressor of cytokine signaling 2 (SOCS2). Detailed analysis of SOCS2 promoter demonstrated its direct transcriptional regulation by STAT5b upon GH stimulation. A novel response element was identified within the first intron of the human SOCS2 gene composed of an E-box followed by tandem STAT5b binding sites, both of which are required for full GH responsiveness. In summary, we demonstrate the power of combining transcript profiling with phylogenetic sequence analysis to define novel regulatory paradigms.


Key words: STAT5b • Growth hormone • transcription • SOCS • promoter • microarray • phylogenetic footprinting




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
V. Wauthier and D. J. Waxman
Sex-Specific Early Growth Hormone Response Genes in Rat Liver
Mol. Endocrinol., August 1, 2008; 22(8): 1962 - 1974.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Hosui and L. Hennighausen
Genomic dissection of the cytokine-controlled STAT5 signaling network in liver
Physiol Genomics, July 9, 2008; 34(2): 135 - 143.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. L. Barclay, S. T. Anderson, M. J. Waters, and J. D. Curlewis
Regulation of Suppressor of Cytokine Signaling 3 (SOC3) by Growth Hormone in Pro-B Cells
Mol. Endocrinol., October 1, 2007; 21(10): 2503 - 2515.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Jiang, Y. Wang, M. Wu, Z. Gu, S. J. Frank, and R. Torres-Diaz
Growth Hormone Stimulates Hepatic Expression of Bovine Growth Hormone Receptor Messenger Ribonucleic Acid through Signal Transducer and Activator of Transcription 5 Activation of a Major Growth Hormone Receptor Gene Promoter
Endocrinology, July 1, 2007; 148(7): 3307 - 3315.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Ono, D. J. Chia, R. Merino-Martinez, A. Flores-Morales, T. G. Unterman, and P. Rotwein
Signal Transducer and Activator of Transcription (Stat) 5b-Mediated Inhibition of Insulin-Like Growth Factor Binding Protein-1 Gene Transcription: A Mechanism for Repression of Gene Expression by Growth Hormone
Mol. Endocrinol., June 1, 2007; 21(6): 1443 - 1457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society